EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer

Mulham Al-Nader iD, Claudia Kesch, Osama Mahmoud, Boris A Hadaschik, Jan Fichtner, Guenther Carl, Günter Feick, Martin Burchardt, Volker Zimmermanns, Lukas Prause, Bülent Polat, Andreas Blana und 32 weitere

BJU International · 2026-04 · 137 (4) · 716-727

DOI: 10.1111/bju.70167 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJU International, online erschienen am 16.02.2026. Verfasst von Mulham Al-Nader und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Essen, Essen, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Patient Reported Outcome Measures, Watchful Waiting, Prostatectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To prospectively evaluate functional patient‐reported outcomes (PROs) in patients with low‐risk prostate cancer (PCa) managed with active surveillance (AS), nerve‐sparing radical prostatectomy (NS‐RP), non‐NS‐RP, or radiotherapy (RT). Patients and Methods This multicentre prospective cohort study used data from the Prostate Cancer Outcomes (PCO) study in Germany, Austria and Switzerland, including 6265 patients with low‐risk PCa enrolled between 2016 and 2023. PROs were assessed at baseline and 12 months after treatment/enrolment using the 26‐item Expanded Prostate Cancer Index Composite Short Form (EPIC‐26), measuring urinary continence, bowel, sexual, hormonal, and irritative/obstructive symptoms. Mean score changes were compared with minimal important differences (MIDs) to determine clinical significance.

Results

In all, 475, 4352, 813, and 625 patients received AS, NS‐RP, non‐NS‐RP, and RT, respectively. At 12 months, AS was associated with stable function across all EPIC‐26 domains. In contrast, both RP groups experienced significant declines in urinary continence (NS‐RP: −18 points; non‐NS‐RP: −26 points) and sexual function (NS‐RP: −35 points; non‐NS‐RP: −30 points), exceeding MID thresholds. Urinary continence did not decline after RT but clinically relevant declines occurred in irritative/obstructive urinary (−5 points), bowel (−7 points), hormonal (−5 points), and sexual function (−12 points). Age‐stratified analysis showed clinically significant declines in urinary and sexual function after NS‐RP across all age groups, with the greatest loss in sexual function among younger patients and the most pronounced continence impairment in the 70–79 years age group. In contrast, functional outcomes under AS remained stable in all age cohorts.

Conclusion

Active surveillance is underutilised in the observed cohort. Prospective PCO data demonstrates that AS preserves urinary continence and sexual function compared to active treatment, supporting its role as the first‐line strategy for suitable candidates. Despite advancements including NS techniques, RP, and to a lesser extent RT, remain associated with substantial functional impairment even in younger men.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPatient Reported Outcome MeasuresWatchful WaitingProstatectomyHumansMaleProspective StudiesAgedMiddle AgedUrinary Incontinence

Stichwörter der Autor:innen

Overtreatmentactive surveillancepatient‐reported outcomesprostate cancerradical treatment

Autor:innen und Institutionen

  • Department of Urology, University Hospital Essen, Essen, Germany.
  • Department of Urology, Johanniter Hospital, Oberhausen, Germany.
  • Bundesverband Prostatakrebs Selbsthilfe e.V., Bonn, Germany.
  • Department of Urology, University Medicine Greifswald, Greifswald, Germany.
  • Department of Urology, Siloah St. Trudpert Klinikum, Pforzheim, Germany.
  • Department of Urology, Kantonsspital Aarau, Aarau, Switzerland.

ORCID-Profile: Mulham Al-Nader, Alexander Winter

Zitieren

APA

Al-Nader, M., Kesch, C., Mahmoud, O., Hadaschik, B. A., Fichtner, J., Carl, G., Feick, G., Burchardt, M., Zimmermanns, V., Prause, L., Polat, B., Blana, A., Horstmann, M., Saar, M., Miglierini, P., Almansur, K., Hefermehl, L., Porres, D., Peters, I., …, & Sibert, N. T. (2026). Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer. BJU International, 137(4), 716-727. https://doi.org/10.1111/bju.70167

Vancouver

Al-Nader M, Kesch C, Mahmoud O, Hadaschik BA, Fichtner J, Carl G, et al. Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer. BJU International. 2026;137(4):716-727. doi:10.1111/bju.70167

BibTeX
@article{AlNader2026,
  author = {Al-Nader, Mulham and Kesch, Claudia and Mahmoud, Osama and Hadaschik, Boris A and Fichtner, Jan and Carl, Guenther and Feick, Günter and Burchardt, Martin and Zimmermanns, Volker and Prause, Lukas and Polat, Bülent and Blana, Andreas and Horstmann, Marcus and Saar, Matthias and Miglierini, Petra and Almansur, Kinan and Hefermehl, Lukas and Porres, Daniel and Peters, Inga and Wiens, Kristina and Palisaar, Rein Jüri and Winter, Alexander and Neisius, Andreas and Kunzmann, Eva-Maria and Harke, Nina Natascha and Bolenz, Christian and Albarghouth, Mohamad Hatem and Manka, Lukas and Kramer, Mario and Luger, Ferdinand and Knoll, Thomas and Pfitzenmaier, Jesco and Brock, Marko and Schittko, Julia and Sommer, Jens Peter and Reichert, Matthias and Lenart, Sebastian and Huber, Philipp and Hijazi, Sameh and Calderaro, Anna and Hermanns, Thomas and Tonhauser, Jens and Kowalski, Christoph and Sibert, Nora Tabea},
  title = {Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer},
  journal = {BJU International},
  year = {2026},
  volume = {137},
  number = {4},
  pages = {716--727},
  doi = {10.1111/bju.70167}
}
Kostenlos starten →